Peripheral Vascular Devices | Market Insights | Latin America | 2022
While the COVID-19 pandemic will have a negative impact on the Latin American peripheral vascular device market in the short term, a large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost constraints in the region’s publicly funded health care systems continue to hinder adoption of premium-priced DCBs and DES and limit the pace of revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Latin America across an 11-year period.
Related Medtech Insights Reports
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…
